Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06720766

Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity

Sponsor: The Third People's Hospital of Chengdu

View on ClinicalTrials.gov

Summary

The non-invasive evaluation of liver steatosis and fibrosis with FibroScan is a routinely procedure in clinical practice for people with obesity. However, there are still considerable uncertainties regarding the potential influence of confounding factors and the optimal application of cut-off values for obesity. The goal of this observational study is to learn about the optimal application of cut-off values of for Chinese people with obesity.

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

OBSERVATIONAL

Enrollment

600

Start Date

2023-10-24

Completion Date

2025-03-31

Last Updated

2024-12-06

Healthy Volunteers

Not specified

Interventions

DIAGNOSTIC_TEST

FibbroScan and biopsy

In individuals with obesity, a biopsy is performed within a week after undergoing an FibroScan examination.

Locations (1)

The Third People's Hospital of Chengdu

Chengdu, Sichuan, China